Sign in

You're signed outSign in or to get full access.

Stephen F. Flatt

Stephen F. Flatt

Chief Executive Officer at NATIONAL HEALTHCARENATIONAL HEALTHCARE
CEO
Executive
Board

About Stephen F. Flatt

Stephen F. “Steve” Flatt, 69, is Chief Executive Officer (since Jan 1, 2017) and an inside director of National HealthCare Corporation; he joined NHC in 2005 as SVP–Development and became President in 2009. He holds a B.A. from David Lipscomb College and an M.S. and Ph.D. from George Peabody College of Vanderbilt University . NHC’s pay-versus-performance disclosure shows total shareholder return of 145.07 for 2019–2024 (vs S&P Healthcare 146.89) and identifies Net Income and Adjusted Income Before Income Taxes as company-selected performance measures . Recent multi-year revenue and EBITDA trends are below.

MetricFY 2020FY 2021FY 2022FY 2023FY 2024
Revenues ($USD)931,795,000*965,542,000*1,029,085,000*1,087,614,000*1,251,759,000*
EBITDA ($USD)56,507,000*37,307,000*57,763,000*93,262,000*122,435,000*

Values retrieved from S&P Global.

Past Roles

OrganizationRoleYearsStrategic Impact / Notes
National HealthCare CorporationCEO; Director2017–presentInside director; CEO evaluated on overall company performance .
National HealthCare CorporationPresident2009–2016Executive leadership prior to CEO appointment .
National HealthCare CorporationSVP – Development2005–2008Joined NHC June 2005 .
Lipscomb UniversityPresident1997–2005Led the university prior to joining NHC .
Ezell Harding Christian SchoolPresidentPrior to 1997K–12 leadership experience .
Lipscomb UniversityVP, Financial Affairs & Institutional PlanningPrior periodFinancial and planning leadership .

External Roles

OrganizationCapacityYearsNotes
Council for Post Acute Care (CPAC)Co-ChairRecent, priorIndustry leadership .
American Health Care Association (AHCA)Board of GovernorsRecent, priorIndustry policy/execution exposure .
Nashville Health Care CouncilBoard Member; Health Care Fellows (2013)PriorRegional healthcare ecosystem; 2013 fellow .
Community Foundation of Rutherford CountyDirectorCurrentCommunity engagement .
Tennessee Business Leadership Council (TBLC)DirectorCurrentState business leadership .
Recognition“Health-Care Heroes,” Nashville Business Journal2013Recognition for healthcare leadership .

Fixed Compensation

Component202220232024
Base Salary ($)522,175528,000559,819
All Other Compensation ($)12,92713,42519,284 (includes 401(k) and Key Employee Plan matches)
Pension— (No pension plans offered)

Additional notes:

  • Deferrals (2024): $114,000 to Key Employee Plan; $8,622 to 401(k) .
  • The company uses AON and peer proxy data for benchmarking; no fixed employment agreements; indemnification agreements in place .

Performance Compensation

NHC funds a management Bonus Pool equal to 5% of pre-tax earnings excluding unrealized gains/losses on marketable securities; for 2024 this pool was $5,264,459 (based on $105,289,176 pre-tax metric). CEO and NEO bonuses are 80% cash / 20% restricted stock, with RS vesting 1/3 on Jan 1 of each of the next three years .

Metric/InstrumentWeighting/TermsTargetActual/PayoutVesting/Key Dates
Company Pre-tax Earnings (excl. unrealized securities)40% of CEO bonus tied to overall financial performanceNot disclosedPool funded at 5% of $105,289,176; CEO cash bonus $1,060,000RS portion vests 1/3 on 1/1/26, 1/1/27, 1/1/28; RS price basis $90.95 (2/8/24 close)
CEO Qualitative Objectives (quality, capital structure, internal control, Board/shareholder comms., succession, LT growth, overall financials, customer/investor satisfaction)60% of CEO bonusNot disclosedIncorporated into 2024 bonus allocationSame RS vesting terms as above
2024 Restricted Stock from Bonus20% of CEO’s earned bonus; 2,914 sharesGranted based on $90.95 priceVests 1/1/26, 1/1/27, 1/1/28
2024 Stock Options15,000 options @ $94.10; granted 3/5/24; 5-year termGrant-date fair value $243,420Vest ratably over 3 years; expire 3/5/2029

2025 plan: unchanged design; pool remains 5% of pre-tax (excl. unrealized), 80% cash / 20% RS; 2025 RS to be priced at $103.55 (2/13/25 close), vesting 1/3 on 1/1/27, 1/1/28, 1/1/29 .

Equity Ownership & Alignment

ItemDetail
Beneficial Ownership (3/14/25)72,313 shares; includes 5,269 restricted stock and 14,734 options; of these, 2,500 common shares are held in a margin account .
Ownership % of SO~0.47% (72,313 / 15,461,829 shares outstanding as of 3/14/25) .
Unexercised Options (12/31/24)15,000 (2024 grant @ $94.10, exp. 3/5/29); 10,000 (2023 grant @ $53.94, exp. 3/8/28); 4,734 (2022 grant @ $63.96, exp. 2/18/27); vest ratably over 3 years .
Unvested RS (12/31/24)5,384 unearned shares (vest schedule applies) .
2024 Equity Vest/Exercise2,651 shares vested (RS); 2,496 options exercised ($248,283 value realized) .
Hedging/Pledging PolicyHedging prohibited (2020 policy; reinforced 11/7/24 in Insider Trading Policy). Disclosure notes 2,500 S. Flatt shares in a margin account; CFO had 5,000 shares pledged. No explicit executive ownership guidelines disclosed .
ClawbackCompensation recoupment policy adopted 11/2/2023 .

Employment Terms

ProvisionStatus
Employment AgreementNone (no employment contracts with executive officers) .
SeveranceNo separate severance agreements disclosed; indemnification agreements in place .
Change-in-Control2020 Omnibus Equity Incentive Plan provides acceleration; estimated CoC value to CEO (as of 12/31/24) $2,000,585 for unvested options and RS .
Non-Compete/Non-SolicitNot disclosed in proxy.
Deferred CompensationKey Employee Plan (non-qualified) available; company matches 15% of contribution to the extent invested in NHC stock; CEO contributed $114,000 in 2024 .

Board Governance (Director Service, Roles, Dual-Role Implications)

  • Board service: Director term expires in 2025; nominated for re-election for a three-year term at the 2025 meeting .
  • Independence: Board determined all directors except Mr. Flatt are independent; Board met 5 times in 2024, all directors attended at least 75% of meetings .
  • Leadership structure: Separate CEO and non-executive Chair (Robert G. Adams); committees (Audit, Compensation, Nominating & Governance) are fully independent and separately chaired .
  • Committee roles: As CEO and inside director, Mr. Flatt does not serve on independent committees .
  • Director compensation: CEO receives no additional compensation for Board service .

Director Compensation (Board-level, not CEO pay)

Element2024 Policy / Amount
Cash fees$3,000 per scheduled meeting attended; additional annual chair fees: Audit Chair $8,000; Comp and Nominating Chairs $4,000 .
EquityAnnual 7,500-share option grant to non-employee directors, 1-year vest, 5-year term, strike = meeting day close .
Discretionary bonus to directors$125,000 cash (used to exercise options or buy stock) for each non-employee director in 2024 .

Compensation Structure Analysis (Signals)

  • Cash vs equity mix: CEO’s 2024 pay included $1,060,000 cash bonus and RS portion (2,914 shares), plus annual stock options; mix continues to emphasize at-risk pay tied to company performance/qualitative goals .
  • Plan stability: 2025 plan unchanged (pool formula and 80/20 cash/RS split), indicating continuity rather than loosening standards .
  • Clawback and hedging restrictions: Strengthened governance via clawback (11/2/23) and insider trading/hedging policy update (11/7/24) .

Say-on-Pay & Shareholder Feedback

Year/ItemOutcome
Say-on-pay (2024 meeting)Approved by over 98% of votes cast .
FrequencyAnnual say-on-pay votes beginning in 2024 .

Performance & Track Record

Measure20202021202220232024
Net Income ($)41,871,000138,590,00022,445,00066,798,000101,927,000
Adjusted Income Before Taxes ($)76,270,000163,404,00045,505,00075,304,000105,289,000
TSR (Indexed to $100 at 12/31/2019)79.2083.4375.58121.89145.07

Company notes 2024 audit fee increase was primarily due to work associated with the White Oak portfolio acquisition (execution activity under his tenure) .

Risk Indicators & Red Flags

  • Hedging prohibited; updated insider trading policy and blackout periods in place .
  • Pledging/margin: Disclosure notes CEO holds 2,500 shares in a margin account; CFO has 5,000 shares pledged—monitor for potential collateral calls or perceived misalignment risk .
  • Related party framework: Formal related-party review policy; significant leases and relationships with NHI disclosed; governance controls described .

Equity Vesting and Potential Selling Pressure

InstrumentQuantityKey Dates
2024 RS from bonus2,914 sharesVests 1/3 on 1/1/26, 1/3 on 1/1/27, 1/3 on 1/1/28 .
2025 RS (prospective)Amount = 20% of 2025 bonus priced at $103.55 (2/13/25)Vests 1/3 on 1/1/27, 1/1/28, 1/1/29 .
2024 Options15,000 @ $94.10Vest ratably over 3 years; expire 3/5/29 .
2023 Options10,000 @ $53.94Vest ratably over 3 years; expire 3/8/28 .
2022 Options4,734 @ $63.96Vest ratably over 3 years; expire 2/18/27 .
2024 Exercises2,496 options exercised; $248,283 value realized2024 .

Regular January 1 RS vest dates create recurring potential for Form 4 activity and trading windows, subject to blackout policy .

Compensation & Incentives (Detail)

Item2024 Amount/Value
Base Salary$559,819 .
Bonus (Cash)$1,060,000 .
Bonus (RS portion)2,914 shares based on $90.95 price; 3-year vest .
Stock Options (Annual)15,000 @ $94.10; grant-date FV $243,420; 3-year vest; 5-year term .
Equity Outstanding (12/31/24)Unvested RS 5,384; unexercised options 15,000/10,000/4,734 with strikes/expirations as above .
CoC Acceleration (12/31/24)$2,000,585 estimated value if change in control event occurred .
ClawbackAdopted 11/2/23 .

Equity Ownership & Alignment (Supplemental Data)

MetricValue
Shares Outstanding (3/14/25)15,461,829 .
CEO Beneficial Ownership72,313 shares (incl. 5,269 RS; 14,734 options; 2,500 shares in margin account) .
Directors & Officers as a Group2,314,144 shares (14.97%); includes 261,433 options and 19,394 RS .

Compensation Committee & Peer Benchmarking

  • Committee: Independent (Chair Emil E. Hassan; members Abernathy, LaRoche, Trail). Met Feb 8 and May 9, 2024; Feb 13, 2025 .
  • Process: Reviews AON and SEC proxy benchmark data; CEO long-term incentives consider company performance, TSR, comparable CEO awards, and grant history .
  • No consultant conflicts disclosed; historical approach emphasizes at-risk pay and broad Partner alignment .

Investment Implications

  • Pay-for-performance alignment: The bonus pool formula (5% of adjusted pre-tax earnings) and 80/20 cash/RS split creates line-of-sight to profitability while building equity ownership; annual option grants add longer-dated leverage. Presence of a clawback and anti-hedging policy strengthens governance and reduces tail risk .
  • Retention and selling pressure: Multi-year RS vesting and staggered option schedules promote retention but create predictable January vest events and potential Form 4 activity; CEO exercised 2,496 options in 2024, and RS vesting continues 2026–2029 based on recent grants .
  • Alignment and risk flags: CEO holds 2,500 shares in a margin account (monitor collateral risk), while CFO has pledged shares; otherwise, hedging is prohibited and say-on-pay support is strong (98%+), lowering governance controversy risk .
  • Change-of-control economics: Acceleration under the 2020 plan yields an estimated $2.0M vesting value for the CEO at 12/31/24, indicating meaningful alignment but also potential golden-parachute optics in a sale scenario .
  • Performance backdrop: TSR recovery to 145.07 (2019–2024) and rising adjusted pre-tax income support incentive payouts; diligence on execution (e.g., White Oak portfolio integration signaled via audit fee drivers) remains key to sustained value creation .

Notes:

  • All citations refer to NHC’s 2025 DEF 14A unless otherwise indicated.
  • Financial trend table values marked with an asterisk were retrieved from S&P Global.